Gene Panel Market by Technique, Product, Application, End-User

KEY MARKET STATISTICS
Base Year [2023]	USD 3.11 billion
Estimated Year [2024]	USD 3.41 billion
Forecast Year [2030]	USD 6.06 billion
CAGR (%)	9.99%

The FPNV Positioning Matrix is pivotal in evaluating the Gene Panel Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Gene Panel Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Gene Panel Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Arizona Oncology, ARUP Laboratories, Becton, Dickinson, and Company, BGI Group, Bio-Rad Laboratories, Inc., Blueprint Genetics Oy by Quest Diagnostics, CENTOGENE N.V., Cepheid by Danaher Corporation, Eurofins Genomics LLC, Everything Genetic Ltd., Fulgent Genetics, Genewiz by Azenta Life Sciences, Guardant Health, Inc., Illumina Inc., myGenomics, Myriad Genetic Laboratories Inc., NanoString Technologies, Inc., Natera, Inc., Novogene Co, Ltd., PrimBio Research Institute, Qiagen N.V., Thermo Fisher Scientific Inc., and Twist Bioscience.

Market Segmentation & Coverage

This research report categorizes the Gene Panel Market to forecast the revenues and analyze trends in each of the following sub-markets:

Technique
- Microarray
- Next-Generation Sequencing
- Polymerase Chain Reaction
Product
- Test Kits
- Testing Services
Application
- Cancer Diagnostics
- Genetic Disorders
- Infectious Diseases
- Pharmacogenomics
End-User
- Academic & Research Institutes
- Hospital & Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Gene Panel Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Gene Panel Market?

3. What are the technology trends and regulatory frameworks in the Gene Panel Market?

4. What is the market share of the leading vendors in the Gene Panel Market?

5. Which modes and strategic moves are suitable for entering the Gene Panel Market?

Product Code: MRR-FF012EDC38D7

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Gene Panel Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Surging prevalence of genetic disorders and rare disease
  - 5.1.1.2. Growing need for the personalized medicines
  - 5.1.1.3. Rapid adoption of multi-gene panel testing in oncology practice
- 5.1.2. Restraints
  - 5.1.2.1. Issues in ensuring the security of genetic data
- 5.1.3. Opportunities
  - 5.1.3.1. Favorable government initiatives for population sequencing
  - 5.1.3.2. Introduction of new gene panels based on next-generation sequencing for clinical research
- 5.1.4. Challenges
  - 5.1.4.1. Accuracy concerns and standardization issues in diagnostic testing
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Gene Panel Market, by Technique

6.1. Introduction
6.2. Microarray
6.3. Next-Generation Sequencing
6.4. Polymerase Chain Reaction

7. Gene Panel Market, by Product

7.1. Introduction
7.2. Test Kits
7.3. Testing Services

8. Gene Panel Market, by Application

8.1. Introduction
8.2. Cancer Diagnostics
8.3. Genetic Disorders
8.4. Infectious Diseases
8.5. Pharmacogenomics

9. Gene Panel Market, by End-User

9.1. Introduction
9.2. Academic & Research Institutes
9.3. Hospital & Diagnostic Laboratories
9.4. Pharmaceutical & Biotechnology Companies

10. Americas Gene Panel Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Gene Panel Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Gene Panel Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
- 14.1.1. Agilent Technologies, Inc.
- 14.1.2. Arizona Oncology
- 14.1.3. ARUP Laboratories
- 14.1.4. Becton, Dickinson, and Company
- 14.1.5. BGI Group
- 14.1.6. Bio-Rad Laboratories, Inc.
- 14.1.7. Blueprint Genetics Oy by Quest Diagnostics
- 14.1.8. CENTOGENE N.V.
- 14.1.9. Cepheid by Danaher Corporation
- 14.1.10. Eurofins Genomics LLC
- 14.1.11. Everything Genetic Ltd.
- 14.1.12. Fulgent Genetics
- 14.1.13. Genewiz by Azenta Life Sciences
- 14.1.14. Guardant Health, Inc.
- 14.1.15. Illumina Inc.
- 14.1.16. myGenomics
- 14.1.17. Myriad Genetic Laboratories Inc.
- 14.1.18. NanoString Technologies, Inc.
- 14.1.19. Natera, Inc.
- 14.1.20. Novogene Co, Ltd.
- 14.1.21. PrimBio Research Institute
- 14.1.22. Qiagen N.V.
- 14.1.23. Thermo Fisher Scientific Inc.
- 14.1.24. Twist Bioscience
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing